Research and Development

The Research and Development team at Neurimmune Holding is dedicated to advancing innovative immunotherapeutics by driving the discovery and development of new antibody-based therapies. This cross-functional team collaborates on Translational Medicine initiatives, utilizes cutting-edge automation in antibody discovery, and leads drug discovery projects to translate scientific discoveries into clinical applications, ultimately aiming to bring effective treatments to patients with unmet medical needs.